Shared on06 Oct 25Fair value Increased 2.17%
Analysts have raised their price target for IHH Healthcare Berhad from RM8.24 to RM8.42, with modest improvements in revenue growth forecasts cited as the primary driver for the adjustment. What's in the News IHH Healthcare Berhad has announced an interim single tier cash dividend of RMB 0.050 per ordinary share for the financial year ending 31 December 2025 (Key Developments).
Shared on23 Apr 25Fair value Decreased 0.12%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 1.33%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25Fair value Increased 0.12%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Increased 0.49%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on12 Mar 25Fair value Decreased 0.42%
AnalystConsensusTarget has increased revenue growth from 7.2% to 8.8%, decreased profit margin from 12.0% to 8.7% and decreased future PE multiple from 41.4x to 33.9x.